View Item 

Show simple item record

Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
dc.contributor.authorSoria, Francesco
dc.contributor.authorBlack, Peter C.
dc.contributor.authorFairey, Adrian S.
dc.contributor.authorCookson, Michael S.
dc.contributor.authorYu, Evan Y.
dc.contributor.authorKassouf, Wassim
dc.contributor.authorDall’Era, Marc A.
dc.contributor.authorSridhar, Srikala S.
dc.contributor.authorMcGrath, John S.
dc.contributor.authorWright, Jonathan L.
dc.contributor.authorThorpe, Andrew C.
dc.contributor.authorMorgan, Todd M.
dc.contributor.authorDaneshmand, Siamak
dc.contributor.authorHolzbeierlein, Jeff M.
dc.contributor.authorBivalacqua, Trinity J.
dc.contributor.authorNorth, Scott
dc.contributor.authorBarocas, Daniel A.
dc.contributor.authorLotan, Yair
dc.contributor.authorGrivas, Petros
dc.contributor.authorStephenson, Andrew J.
dc.contributor.authorShah, Jay B.
dc.contributor.authorRhijn, Bas W.
dc.contributor.authorSpiess, Philippe E.
dc.contributor.authorShariat, Shahrokh F.
dc.contributor.authorGontero, Paolo
dc.date.accessioned2021-07-01T20:14:02Z
dc.date.available2022-08-01 16:14:01en
dc.date.available2021-07-01T20:14:02Z
dc.date.issued2021-07
dc.identifier.citationSoria, Francesco; Black, Peter C.; Fairey, Adrian S.; Cookson, Michael S.; Yu, Evan Y.; Kassouf, Wassim; Dall’Era, Marc A.; Sridhar, Srikala S.; McGrath, John S.; Wright, Jonathan L.; Thorpe, Andrew C.; Morgan, Todd M.; Daneshmand, Siamak; Holzbeierlein, Jeff M.; Bivalacqua, Trinity J.; North, Scott; Barocas, Daniel A.; Lotan, Yair; Grivas, Petros; Stephenson, Andrew J.; Shah, Jay B.; Rhijn, Bas W.; Spiess, Philippe E.; Shariat, Shahrokh F.; Gontero, Paolo (2021). "Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis." BJU International (1): 79-87.
dc.identifier.issn1464-4096
dc.identifier.issn1464-410X
dc.identifier.urihttps://hdl.handle.net/2027.42/168363
dc.publisherWiley Periodicals, Inc.
dc.subject.other#utuc
dc.subject.otherneoadjuvant chemotherapy
dc.subject.otherbladder cancer
dc.subject.otherclinical T2
dc.subject.otherhydronephrosis
dc.subject.otherdownstaging
dc.subject.other#BladderCancer
dc.subject.other#blcsm
dc.subject.other#uroonc
dc.titleNeoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168363/1/bju15289.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168363/2/bju15289_am.pdf
dc.identifier.doi10.1111/bju.15289
dc.identifier.sourceBJU International
dc.identifier.citedreferenceLiu W, Tian J, Zhang S et al. The utilization status of neoadjuvant chemotherapy in muscle‐invasive bladder cancer: a systematic review and meta‐analysis. Minerva Urol Nefrol 2020 [Online ahead of print]. DOI: https://doi.org/10.23736/S0393‐2249.19.03648‐8
dc.identifier.citedreferenceWitjes JA, Bruins HM, Cathomas R et al. European Association of Urology guidelines on muscle‐invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 2020 [Online ahead of print]. DOI: https://doi.org/10.1016/j.eururo.2020.03.055
dc.identifier.citedreferenceZargar H, Zargar‐Shoshtari K, Lotan Y et al. Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer‐does pT0 predict better survival than pTa/Tis/T1? J Urol 2016; 195: 886 – 93
dc.identifier.citedreferenceMartini T, Gilfrich C, Mayr R et al. The use of neoadjuvant chemotherapy in patients with urothelial carcinoma of the bladder: current practice among clinicians. Clin Genitourin Cancer 2017; 15: 356 – 62
dc.identifier.citedreferenceBlack PC, Brown GA, Grossman HB, Dinney CP. Neoadjuvant chemotherapy for bladder cancer. World J Urol 2006; 24: 531 – 42
dc.identifier.citedreferenceRosenblatt R, Sherif A, Rintala E et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle‐invasive urothelial bladder cancer. Eur Urol 2012; 61: 1229 – 38
dc.identifier.citedreferenceHermans TJ, Voskuilen CS, Deelen M et al. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3‐4aN0M0 compared to cT2N0M0 bladder cancer. Int J Cancer 2019; 144: 1453 – 9
dc.identifier.citedreferenceAdvanced Bladder Cancer Overview Collaboration. Advanced Bladder Cancer Meta‐analysis Collaboration. Neo‐adjuvant chemotherapy for invasive bladder cancer. Cochrane Database Syst Rev 2004; 2: CD005246
dc.identifier.citedreferenceWinquist E, Kirchner TS, Segal R, Chin J, Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta‐analysis. J Urol 2004; 171: 561 – 9
dc.identifier.citedreferenceSherif A, Holmberg L, Rintala E et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol 2004; 45: 297 – 303
dc.identifier.citedreferenceGreen DA, Rink M, Hansen J et al. Accurate preoperative prediction of non‐organ‐confined bladder urothelial carcinoma at cystectomy. BJU Int 2013; 111: 404 – 11
dc.identifier.citedreferenceCulp SH, Dickstein RJ, Grossman HB et al. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol 2014; 191: 40 – 7
dc.identifier.citedreferenceMoschini M, Soria F, Klatte T et al. Validation of preoperative risk grouping of the selection of patients most likely to benefit from neoadjuvant chemotherapy before radical cystectomy. Clin Genitourin Cancer 2017; 15: e267 – 73
dc.identifier.citedreferenceGriffiths G. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle‐invasive bladder cancer: long‐term results of the BA06 30894 trial. J Clin Oncol 2011; 29: 2171 – 7
dc.identifier.citedreferenceGrossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859 – 66
dc.identifier.citedreferenceYin M, Joshi M, Meijer RP et al. Neoadjuvant chemotherapy for muscle‐invasive bladder cancer: a systematic review and two‐step meta‐analysis. Oncologist 2016; 21: 708 – 15
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bju15289.pdf
Size:
615.5KB
Format:
PDF
View/Open
Name:
bju15289_am.pdf
Size:
728.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.